Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology Group. [electronic resource]
Producer: 20150611Description: 629-36 p. digitalISSN:- 1545-5017
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Child
- Child, Preschool
- Cytarabine -- administration & dosage
- Disease-Free Survival
- Enzyme Inhibitors -- administration & dosage
- Farnesyl-Diphosphate Farnesyltransferase -- antagonists & inhibitors
- Female
- Hematopoietic Stem Cell Transplantation
- Humans
- Infant
- Isotretinoin -- administration & dosage
- Leukemia, Myelomonocytic, Juvenile -- drug therapy
- Male
- Middle Aged
- Quinolones -- administration & dosage
- Survival Rate
- Vidarabine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.